Bionter AG

https://www.bionter.com

LinkedIn: https://www.linkedin.com/company/bionter

Bionter is a Swiss-based Biotech start-up. Since the foundation in 2020, Bionter has established successful prototype testing with global Pharma companies, received successful seed funding from the US investor Dynamk Capital and launched their first product in Europe and the US. The team has significant experience in particle analytics as well as the commercialization of analytical testing products. Bionter’s first product, EVE, is a fully automated particle counter, that works non-destructive with the sample used and is fully compliant with current regulations. Bionter is a premium supplier of analytical testing solutions and contributes to the benefit of people’s health by helping pharma companies and their service providers to bring drugs faster and safer to the market. *

	Start	2020-08-11 established
	Industry	laboratory equipment and instruments
	Industry 2	EVE particle counter
	Person	Werk, Tobias (Bionter 202204 CEO + Founder)
	Person 2	Schrems, Angelika (Bionter 202305 Global Head of Business Development)

	Region	Riehen BS
	Country	Switzerland
	Street	238 Inzlingerstr.
	City	4125 Riehen
	Tel	+41-77-424-0275
		Address record changed: 2023-07-24

Basic data	Employees	n. a.

		* Document for »About Section«: Bionter AG. (5/8/23). "Press Release: Bionter Announces Partnership Agreement with Midwest Biosolutions to Drive Market Growth in the US". Basel.

		Record changed: 2024-12-29

Picture Berlin Partner Events RegMed Forum 2025 HealthCapital 650x200px

More documents for Bionter AG

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)